Quarterly Result26 May 2026, 04:51 pm
Fermenta Biotech FY26 Revenue Up 14% YoY to ₹547.8 Cr
AI Summary
Fermenta Biotech Ltd announced its FY26 audited financial results, reporting a consolidated revenue of ₹547.8 crore, up 14% YoY. Excluding real estate, revenue stood at ₹538.4 crore, a 26% increase YoY. EBITDA (excluding real estate) rose by 44% YoY to ₹120 crore, driven by strong growth in Vitamin D3 - Human Nutrition. Profit after Tax was ₹70.3 crore, down 8% YoY, impacted by a high base in FY25 due to one-time real estate inflows. The company's German toll manufacturing subsidiary's revenue increased by 101% YoY.
Key Highlights
- Consolidated FY26 EBITDA (excluding real estate) up 44% YoY to ₹120 crore.
- Vitamin D3 Human Nutrition revenue increased by 28% YoY.
- Green chemistry sales more than doubled in FY26.
- German toll manufacturing subsidiary revenue up 101% YoY to ₹76.6 crore.
- FY26 PAT declined 8% YoY to ₹70.3 crore due to high base of real estate income in FY25.
Price Impact
More from FERMENTA